Advertisement
Screener

agilon health, inc. (AGL) Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims

agilon health, inc. Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims

agilon health, inc. (AGL) reported Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims of $2.57 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 · last filed 2026-08-05

  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-06-30 was $1.30B, a 10.31% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-03-31 was $1.27B, a 9.43% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-12-31 was $1.64B, a 8.08% increase year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-09-30 was $1.49B, a 1.09% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2025 was $5.98B, a 2.32% increase from fiscal 2024.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2024 was $5.84B, a 36.54% increase from fiscal 2023.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2023 was $4.28B, a 78.30% increase from fiscal 2022.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2022 was $2.40B, a 45.73% increase from fiscal 2021.
Period endLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 3 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 6 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 9 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 12 month
2026-06-30$1.30B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.57B
10-Q · filed 2026-08-05
$4.21B
derived: sum of 3 quarters · filed 2026-08-05
$5.70B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$1.27B
10-Q · filed 2026-05-06
$2.91B
derived: sum of 2 quarters · filed 2026-05-06
$4.40B
derived: sum of 3 quarters · filed 2026-05-06
$5.85B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$1.64B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.13B
derived: sum of 2 quarters · filed 2026-02-25
$4.58B
derived: sum of 3 quarters · filed 2026-08-05
$5.98B
10-K · filed 2026-02-25
2025-09-30$1.49B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$2.93B
derived: sum of 2 quarters · filed 2026-08-05
$4.34B
10-Q · filed 2025-11-04
$5.86B
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$1.45B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.85B
10-Q · filed 2026-08-05
$4.37B
derived: sum of 3 quarters · filed 2026-08-05
$5.87B
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.40B
10-Q · filed 2026-05-06
$2.92B
derived: sum of 2 quarters · filed 2026-05-06
$4.43B
derived: sum of 3 quarters · filed 2026-05-06
$5.80B
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$1.52B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.02B
derived: sum of 2 quarters · filed 2026-02-25
$4.40B
derived: sum of 3 quarters · filed 2026-02-25
$5.84B
10-K · filed 2026-02-25
2024-09-30$1.51B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$2.88B
derived: sum of 2 quarters · filed 2025-11-04
$4.32B
10-Q · filed 2025-11-04
$5.52B
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$1.37B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$2.82B
10-Q · filed 2025-08-04
$4.01B
derived: sum of 3 quarters · filed 2026-02-25
$5.12B
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$1.44B
10-Q · filed 2025-05-06
$2.64B
derived: sum of 2 quarters · filed 2026-02-25
$3.74B
derived: sum of 3 quarters · filed 2026-02-25
$4.75B
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$1.19B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$2.30B
derived: sum of 2 quarters · filed 2026-02-25
$3.31B
derived: sum of 3 quarters · filed 2026-02-25
$4.28B
10-K · filed 2026-02-25
2023-09-30$1.10B
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$2.11B
derived: sum of 2 quarters · filed 2024-11-07
$3.09B
10-Q · filed 2024-11-07
$3.71B
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$1.01B
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$1.98B
10-Q · filed 2024-08-06
$2.61B
derived: sum of 3 quarters · filed 2025-02-25
$3.23B
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$972.83M
10-Q · filed 2024-05-07
$1.60B
derived: sum of 2 quarters · filed 2025-02-25
$2.22B
derived: sum of 3 quarters · filed 2025-02-25
2022-12-31$628.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$1.25B
derived: sum of 2 quarters · filed 2025-02-25
$2.40B
10-K · filed 2025-02-25
2022-09-30$618.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$1.77B
10-Q · filed 2023-11-02
2022-06-30$1.15B
10-Q · filed 2023-08-03
2021-12-31$1.65B
10-K · filed 2024-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Progyny, Inc. (PGNY)United States$1.994B28.37
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80